Wei Bhatt

Wei Bhatt leads a pediatric CAR-T research program at Children's Hospital Los Angeles focused on developing adoptive cell therapies for pediatric solid tumors. His work has advanced GD2-directed CAR-T cells for osteosarcoma and neuroblastoma, overcoming the challenges of treating solid tumors with cellular therapy. He investigated strategies to improve T cell persistence and infiltration into solid tumor microenvironments in the pediatric context. His clinical and translational research represents the frontier of pediatric cancer immunotherapy.